Quality of life and illness costs in irritable bowel syndrome

Magnus Simrén; John Brazier; Georges Coremans; Michel Dapoigny; Stefan A. Müller-Lissner; Fabio Pace; André J P M Smout; Reinhold W. Stockbrügger; Morten H. Vatn; Peter J. Whorwell

doi:10.1159/000079846

Quality of life and illness costs in irritable bowel syndrome

Magnus Simrén, John Brazier, Georges Coremans, Michel Dapoigny, Stefan A. Müller-Lissner, Fabio Pace, André J P M Smout, Reinhold W. Stockbrügger, Morten H. Vatn, Peter J. Whorwell

Research output: Contribution to journal › Article › peer-review

Abstract

Quality of life is reduced in patients with irritable bowel syndrome, and the costs for this disease are substantial to society. During a meeting in London, UK, the IBiS club reviewed the literature on these subjects. Drawbacks and advantages with existing instruments to assess quality of life and costs were discussed and the clinical and scientific relevance of the current knowledge was assessed. A summary from the meeting is presented in this paper. Copyright © 2004 S. Karger AG, Basel.

Original language	English
Pages (from-to)	254-261
Number of pages	7
Journal	Digestion
Volume	69
Issue number	4
DOIs	https://doi.org/10.1159/000079846
Publication status	Published - 2004

Keywords

Costs of IBS
Health economics in IBS
IBS, cost-benefit
IBS, cost-effectiveness
Irritable bowel syndrome
Quality of life studies in IBS

Access to Document

10.1159/000079846

Cite this

@article{caa22c52d20d4ba7bfea0643956c3b24,

title = "Quality of life and illness costs in irritable bowel syndrome",

abstract = "Quality of life is reduced in patients with irritable bowel syndrome, and the costs for this disease are substantial to society. During a meeting in London, UK, the IBiS club reviewed the literature on these subjects. Drawbacks and advantages with existing instruments to assess quality of life and costs were discussed and the clinical and scientific relevance of the current knowledge was assessed. A summary from the meeting is presented in this paper. Copyright {\textcopyright} 2004 S. Karger AG, Basel.",

keywords = "Costs of IBS, Health economics in IBS, IBS, cost-benefit, IBS, cost-effectiveness, Irritable bowel syndrome, Quality of life studies in IBS",

author = "Magnus Simr{\'e}n and John Brazier and Georges Coremans and Michel Dapoigny and M{\"u}ller-Lissner, {Stefan A.} and Fabio Pace and Smout, {Andr{\'e} J P M} and Stockbr{\"u}gger, {Reinhold W.} and Vatn, {Morten H.} and Whorwell, {Peter J.}",

year = "2004",

doi = "10.1159/000079846",

language = "English",

volume = "69",

pages = "254--261",

journal = "Digestion",

issn = "0012-2823",

publisher = "S. Karger AG",

number = "4",

}

TY - JOUR

T1 - Quality of life and illness costs in irritable bowel syndrome

AU - Simrén, Magnus

AU - Brazier, John

AU - Coremans, Georges

AU - Dapoigny, Michel

AU - Müller-Lissner, Stefan A.

AU - Pace, Fabio

AU - Smout, André J P M

AU - Stockbrügger, Reinhold W.

AU - Vatn, Morten H.

AU - Whorwell, Peter J.

PY - 2004

Y1 - 2004

N2 - Quality of life is reduced in patients with irritable bowel syndrome, and the costs for this disease are substantial to society. During a meeting in London, UK, the IBiS club reviewed the literature on these subjects. Drawbacks and advantages with existing instruments to assess quality of life and costs were discussed and the clinical and scientific relevance of the current knowledge was assessed. A summary from the meeting is presented in this paper. Copyright © 2004 S. Karger AG, Basel.

AB - Quality of life is reduced in patients with irritable bowel syndrome, and the costs for this disease are substantial to society. During a meeting in London, UK, the IBiS club reviewed the literature on these subjects. Drawbacks and advantages with existing instruments to assess quality of life and costs were discussed and the clinical and scientific relevance of the current knowledge was assessed. A summary from the meeting is presented in this paper. Copyright © 2004 S. Karger AG, Basel.

KW - Costs of IBS

KW - Health economics in IBS

KW - IBS, cost-benefit

KW - IBS, cost-effectiveness

KW - Irritable bowel syndrome

KW - Quality of life studies in IBS

U2 - 10.1159/000079846

DO - 10.1159/000079846

M3 - Article

SN - 0012-2823

VL - 69

SP - 254

EP - 261

JO - Digestion

JF - Digestion

IS - 4

ER -

Quality of life and illness costs in irritable bowel syndrome

Abstract

Keywords

Access to Document

Fingerprint

Cite this